Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;2024(67):358-370.
doi: 10.1093/jncimonographs/lgae031.

Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study

Affiliations

Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study

Grace Umutesi et al. J Natl Cancer Inst Monogr. .

Abstract

Background: The World Health Organization recommends a single-dose human papillomavirus (HPV) vaccination schedule for girls and boys to accelerate progress toward cervical cancer elimination. We applied the Theoretical Framework of Acceptability (TFA) within the context of HPV vaccination to assess the acceptability of a single-dose schedule among health-care professionals in Kenya.

Methods: A REDCap survey was developed using relevant Theoretical Framework of Acceptability domains and validated with health-care professionals. Descriptive analyses and multivariate Poisson regression were conducted to assess factors associated with increased acceptability. Free-text responses were analyzed using a rapid qualitative approach, and findings were presented using a joint display.

Results: Among 385 responses, 74.2% of health-care professionals were female and 48.6% were nurses. On average, respondents had been in their position for 60 months, and one-third (33.2%) were based at level-4 facilities. The majority (75.84%) thought that giving a single-dose of the HPV vaccine to adolescent girls and young women was either acceptable or very acceptable. Qualitative findings highlighted that lack of information was the underlying reason for health-care professionals who were resistant, and most clinicians thought that a singled-dose schedule was less burdensome to clinicians and patients. Hospital directors had a non-statistically significantly lower acceptability likelihood than nurses (incident rate ratio = 0.93, 95% confidence interval = 0.45 to 1.71) and health-care professionals at urban facilities had a non-statistically significantly lower acceptability likelihood than clinicians in rural facilities (incident rate ratio = 0.97, 95% confidence interval = 0.83 to 1.13).

Conclusion: Although not statistically significant, predictors of increased acceptability provide information to tailor strategies to increase HPV vaccination coverage and accelerate progress toward cervical cancer elimination.

PubMed Disclaimer

Conflict of interest statement

G.U. reports research funding from Sub-Saharan Africa L’Oréal-UNESCO for Women in Science Young Talent program. R.V.B. reports that Regeneron Pharmaceuticals provided abstract and manuscript writing support outside this study. K.N. and N.M. report research funding from the Merck Investigator Studies Program, outside this study.

Figures

Figure 1.
Figure 1.
Flow chart describing responses used to assess the acceptability of the single-dose schedule of human papillomavirus vaccination for adolescent girls and young women among health-care professionals.
Figure 2.
Figure 2.
Determinants of acceptability among health-care professionals. Findings of a multivariate Poisson regression reporting incidence rate ratios with 95% confidence intervals. Model equation: logit (Ym) = αm + B1 job title + B2 religion + B3 referral level + B4 geographic location of the facility + B5 job duration + B6 gender + B7 county + B8 age.

References

    1. Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660 - DOI - PubMed
    1. Zhang X, Zeng Q, Cai W, Ruan W.. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21(1):894. doi:10.1186/s12889-021-10907-5 - DOI - PMC - PubMed
    1. International Vaccine Access Center (IVAC). Human Papillomavirus Vaccine | ViewHub. https://view-hub.org/vaccine/hpv. Accessed January 16, 2024.
    1. Arbyn M, Rousta P, Bruni L, Schollin Ask L, Basu P.. Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer. J Natl Cancer Inst. 2024;116(6):775-778. doi:10.1093/jnci/djae042 - DOI - PMC - PubMed
    1. Spayne J, Hesketh T.. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. BMJ Open. 2021;11(9):e052016. doi:10.1136/bmjopen-2021-052016 - DOI - PMC - PubMed

MeSH terms

Substances